VRTX — Inc. Common Stock

Ownership history in BB BIOTECH AG · 57 quarters on record

This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Inc. Common Stock (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

23.19% (2009 Q4)

Avg. % of fund

9.27%

First filed

1999 Q1

Last filed

2019 Q1

Quarters held

57

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2019 Q1	REDUCED	1,300,000	-70,445	-5.1%	6.01%	$239.1M	$183.95
2018 Q4	UNCHANGED	1,370,445	—	0%	7.28%	$227.1M	$165.71
2018 Q3	REDUCED	1,370,445	-30,000	-2.1%	6.99%	$264.1M	$192.74
2018 Q2	REDUCED	1,400,445	-75,000	-5.1%	6.87%	$238.0M	$169.96

% of Fund (quarterly) VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% MCRAE CAPITAL MANAGEMENT INC 3Y 7Y 3.29% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68%

← Back to BB BIOTECH AG Holdings